Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma

This consensus highlights the urgent need to expand access to anti-GD2 therapy in Latin America as maintenance therapy for newly diagnosed patients with HR-NB and patients with relapsed or refractory neuroblastoma. Collaboration between health policymakers, the pharmaceutical industry, the Global Platform for Access to Childhood Cancer Medicines, and the pediatric oncology community is essential to address this challenge.

Authors

Institutions

Publication Details

Journal
JCO Global Oncology
Published
2025-12-01
DOI
https://doi.org/10.1200/go-25-00201
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma

Scott C. Howard, Verónica Álvarez, Haydée del Pilar Salazar Rosales, Sima Ferman et al.
JCO Global Oncology
Neuroblastoma Research and Treatments
article

Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma

Scott C. Howard, Verónica Álvarez, Haydée del Pilar Salazar Rosales, Sima Ferman, Beatriz S. C. Silva, Nathalia Halley, Fabiana Morosini, Arissa Ikeda, Mauricio Chaparro, Martín Pérez García, Sandra Alarcón, Vicente Odone Filho, Agustina Pollono, Roy Rosado, Marcelo Coirini, Alejandra Casanovas, Victoria Sobrero, Guido Felizzia, Mariana Alejandra Varela, Mercedes García Lombardi, Diana Valencia, Simone Castro Resende Franco, Alberto Olaya Vargas, Lauro J. Gregianin, Milena Villarroel, Camila Hashimoto, Luis E. Juárez Villegas, Óscar González Ramella, Gabriela I. Villanueva, Lourdes Romero, Soad Fuentes-Alabi, Delia P. Streitenberger, Diego Figueredo, Nevicolino Pereira de Carvalho Filho, Félix Gaytan Morales, Diana Bonilla, Catalina Peters
article en

Abstract

This consensus highlights the urgent need to expand access to anti-GD2 therapy in Latin America as maintenance therapy for newly diagnosed patients with HR-NB and patients with relapsed or refractory neuroblastoma. Collaboration between health policymakers, the pharmaceutical industry, the Global Platform for Access to Childhood Cancer Medicines, and the pediatric oncology community is essential to address this challenge.

JCO Global OncologyVol. 11(11)
Hospital Sant Joan de Déu Barcelona (ES), Instituto Tecnológico de Querétaro (MX), Austral University (AR), Garrahan Hospital (AR), Hospital Israelita Albert Einstein (BR), Centro Hospitalario Pereira Rossell (UY), Hospital Italiano de Buenos Aires (AR), Hospital Pedro de Elizalde (AR), Bariloche Atomic Centre (AR), Clínica Las Condes (CL), Hospital de Clínicas de Porto Alegre (BR), Hospital Infantil de México Federico Gómez (MX), Hospital Roberto del Rio (CL), Hospital Universitario Austral (AR), Hospitales Regionales de Alta Especialidad (MX), Hospital Universitario de Santander (CO), Hospital Luis Calvo Mackenna (CL), Hospital Nacional de Niños Bloom (SV), Hospital de Clínicas "José de San Martín" (AR), Hospital Civil de Guadalajara (MX), Instituto Nacional de Enfermedades Neoplásicas (PE), Fundación Santa Fe de Bogotá (CO), Hospital Universitário de Brasília (BR), Hospital de Niños Superiora Sor María Ludovica (AR), Instituto Nacional de Câncer - INCA (BR), Hospital Santa Marcelina (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Instituto Nacional de Pediatria (MX), Hospital del Niño (PA), Hospital General de Niños Ricardo Gutierrez (AR), Universidad Nacional de Asunción (PY)
Partnerships for the goals
Openalex Percentile: Top 32%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.